Neuroimaging Biomarker for Seizures

NCT03441867 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 224

Last updated 2022-04-05

No results posted yet for this study

Summary

This multi-site study will examine patients with epilepsy (ES) following head injury \[i.e., posttraumatic epilepsy (PTE)\] and posttraumatic psychogenic Non-epileptic seizures (PNES) and will compare them to patients with traumatic brain injury (TBI) who do not have seizures using functional neuroimaging.

Conditions

  • Seizure Disorder
  • Seizure Disorder, Post Traumatic
  • Traumatic Brain Injury
  • Non-Epileptic Seizure
  • Conversion Disorder
  • Magnetic Resonance Imaging
  • Head Injury
  • Epilepsy

Interventions

BEHAVIORAL

Cognitive Behavioral Therapy for Seizures

CBT-informed psychotherapy for patients with PNES and PTE

OTHER

Standard Medical Care

Observational - standard medical care

Sponsors & Collaborators

  • University of Alabama at Birmingham

    collaborator OTHER
  • Rhode Island Hospital

    collaborator OTHER
  • Birmingham, Alabama VA Medical Center

    collaborator FED
  • United States Department of Defense

    collaborator FED
  • Ocean State Research Institute, Inc.

    collaborator OTHER
  • Brown University

    collaborator OTHER
  • Providence VA Medical Center

    lead FED

Principal Investigators

  • W. Curt LaFrance, Jr., MD, MPH · Providence VA Medical Center

  • Jerzy Szarflarski, MD · University of Alabama at Birmingham

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-15
Primary Completion
2022-05-15
Completion
2022-09-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03441867 on ClinicalTrials.gov